CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 196 participants.
Also called NCT03716934
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 196 participants
- Sponsor
- Registry
-
NCT03716934
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT03716934. Randomized; single masking; primary purpose treatment. Start 2018-06-27 (actual); primary completion 2022-04-18 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial
- Acronym
- craft
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Arctic Front Advance® balloon catheter
- Intervention (Drug)
- Antiarrhythmic drug
- Intervention (Device)
- Confirm RX heart monitor® (Abbott)
- Lead sponsor
- Hospital San Carlos, Madrid
Record details
- Record id
cardio:ct-nct03716934- Content hash
d70a403757f9e176ac9dd8e688c9cae6576f133bc650cfb9ff456b1107ba71ee